The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy
- 17 May 2020
- journal article
- review article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (8) , e13906
Abstract
With the implementation of the new kidney allocation system (KAS), there is increased reliance on a virtual crossmatch/histocompatibility risk assessment (vXM) for evaluating potential presence, as well as strength, of HLA antibodies against a potential donor. The accuracy of such an assessment depends on the precision in the identification of the recipient's antibody profile and the potential donor's HLA typing. While the development of the single antigen bead (SAB) multiplex assay has improved the sensitivity and specificity of HLA antibody detection, several limitations of the assay (specific to certain sensitized patients) can complicate accurate interpretation of results. In this report, we focus on the “shared‐epitope” phenomenon, a condition in which antibody strength can be underrepresented, or its presence completely missed, due to binding of the antibody to competing targets on multiple antigens (beads), effectively “diluting” the resulting MFI readout. Here, we provide a relevant background to understand this phenomenon and present a couple of case studies illustrating how it can be investigated, leading to a more accurate histocompatibility consultation.Keywords
This publication has 24 references indexed in Scilit:
- Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting ReportAmerican Journal of Transplantation, 2018
- Impact of cold ischemia time on the outcomes of kidneys with Kidney Donor Profile Index ≥85%: mate kidney analysis - a retrospective studyTransplant International, 2018
- Early Experience with the New Kidney Allocation SystemClinical Journal of the American Society of Nephrology, 2017
- Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney TransplantationJournal of the American College of Surgeons, 2017
- Changes in Deceased Donor Kidney Transplantation One Year After KAS ImplementationAmerican Journal of Transplantation, 2016
- CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patientsHuman Immunology, 2016
- Early Changes in Kidney Distribution under the New Allocation SystemJournal of the American Society of Nephrology, 2015
- Assessing Antibody Strength: Comparison of MFI, C1q, and Titer InformationAmerican Journal of Transplantation, 2015
- Utility of HLA Antibody Testing in Kidney TransplantationJournal of the American Society of Nephrology, 2015
- New National Allocation Policy for Deceased Donor Kidneys in the United States and Possible Effect on Patient OutcomesJournal of the American Society of Nephrology, 2014